Navigation Links
Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
Date:11/14/2012

orbid premature ejaculation and erectile dysfunction (ED).

  • Ampio has completed two phase 3 clinical trials in Europe on Zertane™.
  • Ampio is poised to file an IND for pivotal trials under the 505(b)2 pathway in the USA adhering to the guidance provided by the FDA during our Pre-IND meeting.
  • Ampio has identified sites to conduct its pivotal trials in the USA.
  • Ampio will be filing for approval of Zertane™, based on the European trials results, in Australia (TGA). Approval in Australia will facilitate approval in many countries in Latin America and the Pacific Rim where we have already licensed Zertane™.
  • Ampio has secured a manufacturing agreement with Ethypharm (France) to produce the ODT formulation of Zertane™, which will be used for the pivotal trials in the USA.
  • Ampio entered into a contract with Syngene (Bangalore, India) to manufacture Zertane ED™, which will be used in clinical trials in South Korea, in compliance with FDA standards, by its partner/licensee Daewoong.
  • Ampio was awarded multiple US and international patents on Zertane™ and was recently awarded patents on the combination treatment for PE and ED (as well as patents for the reduction of potential side effects of tramadol) in China, Europe and multiple other countries.
  • Ampio has secured licenses in Brazil and S. Korea for these drugs and is currently in discussions with potential global partners.
  • Ampio has contracted Pharmerit, Inc. (Cambridge, MA) to complete the development of the Patient Outcome for Premature Ejaculation (POPE) patient reported outcome (PRO) tool for the evaluation of premature ejaculation therapy. When completed in the next few weeks this will be the only validated PRO tool for PE in the FDA environment.  The completion of the POPE trial will allow Ampio to file the IND in the USA and conclude its negotiations with phar
    '/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novation Champions Reusable Packaging for Sustainability in Healthcare
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Champions Oncology Reports Financial Results for the Quarter Ended July 31, 2012
4. Terso Solutions partners with Champion Medical Technologies to offer fully automated tracking of Tissue and Implantable Devices
5. Champions Oncology to Present at Rodman & Renshaw Conference
6. Champions Oncology Reports Resignation Of Director
7. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
8. Ampio Pharmaceuticals Announces Closing of Public Offering
9. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
10. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
11. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 The consumer marketing playbook and ... sectors to better identify winning tools and techniques. ... with and understand consumers, as new technologies are ... purchasing decisions. According to recent ... area where organizations can observe a deep pool ...
(Date:7/11/2014)... , July 11, 2014 ... Market by Composition of Material, Application (Healthcare, Homeland ... End Product (Personal Instrument, Hand-Held Instruments, Fixed, and ... Analysis to 2013 - 2020", published by MarketsandMarkets, the Scintillator ... of 5.62% from 2014 to 2020, and reach ...
(Date:7/11/2014)... 2014  Australian drug delivery company, Phosphagenics Limited (ASX: ... A$19.3 million via a placement of A$16.3 million to ... U.S., Asia and ... purchase plan (SPP) to be offered to existing shareholders. ... two tranches. "This capital raising positions us ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3
... HUNTSVILLE, Ala., Nov. 15, 2011 Bayer Technology ... new Bayer MaterialScience production site at Caojing in ... solutions. The new process technology significantly reduces solvent ... and carbon dioxide emissions. (Logo: http://photos.prnewswire.com/prnh/20081211/DECLOGO) ...
... Shurtleff, Inc. (Codman), a global neuroscience and neurovascular company, ... Valve, a shunt used in the treatment of congenital ... (CSF) in the brain.  Over the ... treat approximately 150,000 patients suffering from hydrocephalus in the ...
Cached Medicine Technology:Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China 2Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China 3Codman Launches CERTAS™ Programmable Valve for Hydrocephalus 2Codman Launches CERTAS™ Programmable Valve for Hydrocephalus 3Codman Launches CERTAS™ Programmable Valve for Hydrocephalus 4
(Date:7/13/2014)... 13, 2014 ECS is ... “As a parent of a special needs child, I ... the Seattle community for contemporary special education resources and ... alternative to students and families in the Seattle metro ... environment for special education. We welcome the opportunity to ...
(Date:7/13/2014)... Recently, iFitDress.com, one of the most popular ... has added a new selection of beautiful evening ... launched a promotion for these evening gowns. Now, everybody ... now providing thousands of graceful gowns in its online ... America, France, Italy and many other countries. They are ...
(Date:7/12/2014)... 12, 2014 The Passenger Information System ... 2013 to $20,341.36 million by 2019, at an expected ... 2019. , The public transport infrastructure in North America ... available in almost every corner of the region. The ... of public transport service providers are driving the North ...
(Date:7/12/2014)... 2014 The "North ... Devices Market by Angioplasty Balloon (Plain/Old, ... OCT), IVC Filter (Retrievable), Endovascular Stent ... and studies the major market drivers, ... and Canada. , Browse 108 market ...
(Date:7/12/2014)... 2014 Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ... forward in the federal multidistrict litigation underway in ... Liebhard LLP reports. According to a filing dated ... Stengel has ordered the deposition of a former ... that the witness’s testimony concerning the marketing of ...
Breaking Medicine News(10 mins):Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4
... Dec. 4 Herpes zoster, also known as shingles, is ... pox, according to a Kaiser Permanente study in the December ... The study, the largest of its kind, used electronic health ... varicella (chicken pox) vaccine from 2002 to 2008 in Kaiser ...
... , ... With a membership increase of more than 15 percent since ... its history, but also as a sign of the organization’s relevance. Most ... a time when trade organizations across the nation are suffering significant losses, ...
... , PLAINSBORO, N.J., Dec. 3 ... at Plainsboro (UMCPP) reached a milestone today with a ... at the new hospital that will replace University Medical ... , A topping out ceremony is a steelworkers, tradition ...
... BEIJING, Dec. 3 /PRNewswire-Asia/ -- Long believed to ... important ingredients in global,cuisine, has seen increased demand in China ... timing of this ginger demand increase coincides with supply shortages,effecting ... about,a potential repeat of the current demand hysteria over garlic. ...
... WASHINGTON, Dec. 3 The American Association of Homes ... for passing Sen. Michael Bennet,s (D-Colo.) amendment, which reassures ... keeping savings within the program. , "With the silver ... for health care reform legislation currently before Congress to ...
... Metformin outperforms widely used sulfonylureas, but each patient will be ... -- A class of drugs still taken by millions of ... risk of dying and heart failure than the newer treatment ... of diabetes treatment, performed less well than metformin in a ...
Cached Medicine News:Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
Used for intermittent catheterization of a male or female patient to provide drainage of urine from the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: